Multiple Sclerosis Clinical Trial
Official title:
The Effect of a Targeted Exercise Program on Balance and Postural Responses in Patients With Multiple Sclerosis (MS)
The purpose of this study is to examine the effects of a postural adjustment, targeted training program on balance ability and postural responses anticipatory postural adjustments (APA) and compensatory postural adjustments (CPA) in individuals with MS
| Status | Recruiting |
| Enrollment | 15 |
| Est. completion date | December 1, 2024 |
| Est. primary completion date | December 1, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility | Inclusion Criteria: 1. Must be18 to 70 years of age. 2. Medical diagnosis of MS confirmed by a neurologist. 3. Ability to stand independently without any aid for at least 3 minutes. 4. A Patients determined disease steps (PDDS) score of 5 or lower. 5. Normal or corrected-to-normal vision. 6. English or Spanish speaking. Exclusion Criteria: 1. MS-related exacerbation or medication change in the past two months. 2. Presence of concurrent neurological or orthopedic disorders. 3. Unable to perform the experimental tasks. |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Miami | Miami | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| University of Miami |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in balance ability as measured by the BESTest | The Balance Evaluation Systems Test (BESTest) will be used to measure balance ability. Items are scored from 0 (severe impairment) to 3 (no impairment), with a total score of 108. A higher score suggests better balance ability. | Baseline, 6 weeks (post intervention) | |
| Primary | Change in reaction time | Measure in seconds | Baseline, 6 weeks (post intervention) | |
| Primary | Change in movement velocity | Measure in degree per second | Baseline, 6 weeks (post intervention) | |
| Primary | Change in endpoint excursion percentage | measure of endpoint excursion in a percentage out of a100 | Baseline, 6 weeks (post intervention) | |
| Primary | Change in directional control percentage | measure of directional control in a percentage out of a100 | Baseline, 6 weeks (post intervention) | |
| Primary | Change in maximum excursion percentage | measure of maximum excursion in a percentage out of a100 | Baseline, 6 weeks (post intervention) | |
| Primary | Change in muscle responses latency as measured by MCT | The Motor Control test (MCT) measures the subject's ability to generate a motor response latency to a sudden surface translation in a forward and backward direction at three different magnitudes (small, medium, and large).
Latency: The time-lapse between the perturbation onset and the subject response for each limb. The latency is reported in milliseconds. |
Baseline, 6 weeks (post intervention) | |
| Primary | Change in postural muscles responses latency as measured by Electromyography (EMG) | Postural muscles responses onset latency in seconds | Baseline, 6 weeks (post intervention) | |
| Primary | Change in APA as measured by microvolts | Postural muscles APA measured in microvolts | Baseline, 6 weeks (post intervention) | |
| Primary | Change in CPA as measured by microvolts | Postural muscles CPA in microvolts | Baseline, 6 weeks (post intervention) | |
| Secondary | Change in balance confidence as measured by ABC | The Activities Specific Balance Confidence (ABC) scale is a self-report questionnaire of a subject's perceived level of balance confidence. It measures the subject's confidence in performing various ambulatory activities without falling. There are 16 items scored using a scale(0-100) with higher scores indicating more confidence in performing the tasks. A total score is reported by dividing the total ABC score by 16. | Baseline, 6 weeks (post intervention) | |
| Secondary | Change in quality of life as measured by the MSQoL-54 | Multiple Sclerosis Quality of Life - 54 (MSQoL-54) is a self-report questionnaire measuring subject perceived of quality of life. In total, it contains 54 items with a total score ranging from 0-100, with higher scores indicating a better quality of life | Baseline, 6 weeks (post intervention) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |